Press Release

Issued by .

September 26, 2007

NuBax Limited, the innovative seating technology company, has signed a worldwide licensing agreement for the AeroBax® seating technology with Landmark Aviation, a DAE Engineering company. The deal, announced today at the National Business Aviation Association exhibition in Atlanta could potentially cover all aircraft in the corporate aviation market.

The foam-based AeroBax® technology improves the postural position of an individual while seated, significantly enhancing comfort by maintaining the natural curvature of the spine. AeroBax® not only relieves muscle fatigue by maintaining proper support and posture, but clinical trials performed in the U.S. and U.K. have demonstrated significant health benefits, including increasing the body's blood flow, which can have major implications in reducing thromboembolisms or DVT-like events.

"Landmark Aviation is pleased to offer aircraft owners, manufacturers and operators this new technology for the first time," said Paul Soubry, president and chief executive officer, Landmark Aviation. "By changing the way occupants sit in their seats, AeroBax® improves comfort and can offer important health benefits. The system also offers weight and cost saving opportunities over conventional mechanisms such as adjustable lumbar supports, air bladders and other technologies."

The technology is immediately available for all 9G seat certified aircraft. Landmark and NuBax will develop a system for 16G seat certified aircraft in early 2008. The AeroBax® technology can be incorporated into any aircraft seat without the need for frame or upholstery changes. Landmark Aviation will initially offer the technology in aircraft seats at the company's Springfield, Ill. and Dallas operations. The company's Springfield facility performs a variety of services for business aircraft, including full modifications, paint, avionics and airframe maintenance. Associated Air Centre in Dallas undertakes VIP and luxury completions for transport category aircraft.

"We are delighted to partner with such a renowned and established company as Landmark Aviation", said Hayley Morgan, head of aviation at NuBax. "With the global aspirations of DAE, Landmark provides the ideal platform to develop the AeroBax® name and technology worldwide. In addition to the benefits for aircraft passengers, the technology will be developed and incorporated into crew seats where increased blood flow and a reduction in fatigue are paramount."

NuBax has been developing aviation-based applications for its technology since 2006 and is forging strong links within the aerospace industry in both the commercial and corporate sectors. Earlier this year, the TAG Group became the largest shareholder in NuBax Limited. As well as being a major shareholder in the McLaren Formula 1 Group, TAG is the largest single shareholder of TAG Aviation Group, an international, diversified group of companies providing services for business jet aircraft, and the individuals and corporations who own and fly them. The TAG Aviation Group also owns and operates TAG London Farnborough Airport, which is fully dedicated to business aviation.

NuBax's patented technology can be incorporated into most forms of seating, with automotive, aviation and office furniture currently being the company's primary markets. Two years ago, Lotus became the first car manufacturer to introduce the NuBax technology, branded as ProBax® in all its current road models. The technology is currently being tested by leading vehicle manufacturers where it has both reduced weight and delivered performance benefits. The seating technology has seen further launches in 2007, again under the ProBax® name, for seats used in medical establishments and the work environment.

NuBax is dedicated to the continued evolution of seating in all environments and further establishing the comfort, medical, safety and cost benefits associated with the technology.